Recent market analysis reveals a significant surge in the global Oscillating Positive Expiratory Pressure (OPEP) device market, which is anticipated to reach a valuation of USD 151.30 million by 2024 and expand to USD 263.40 million by 2034. This robust growth represents a steady Compound Annual Growth Rate (CAGR) of 5.70% from 2024 to 2034, driven by increasing adoption of these devices in respiratory therapy.
OPEP devices are gaining traction due to their effectiveness in managing respiratory disorders such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and cystic fibrosis. These devices play a crucial role in enhancing lung function and improving patients’ quality of life.
The integration of OPEP devices with telehealth and digital health platforms is creating new growth opportunities. Remote patient monitoring, data acquisition, and virtual medical consultations are advancing medical care and treatment outcomes. Manufacturers investing in technology integration are poised to benefit from this expanding market.
However, the lengthy and stringent regulatory approval processes for OPEP devices pose a challenge, potentially impeding the launch of new products and constraining growth opportunities.
Regional Outlook:
North America and Europe currently hold significant shares in the OPEP device market. East Asia is projected to experience lucrative growth from 2024 to 2034, driven by an increase in local production and affordable product availability. The rising prevalence of COPD, particularly due to smoking in China and respiratory illnesses among the elderly in Japan, is contributing to market expansion. Despite this, low awareness among healthcare practitioners and patients about OPEP devices remains a barrier.
“The OPEP device market is experiencing steady growth, fueled by increased awareness of respiratory health, rising incidence of respiratory diseases, and innovations in medical system infrastructure. The growing demand for respiratory therapy solutions underscores the market’s investment potential,” comments an analyst at FMI.
Key Takeaways:
- The COPD sector is expected to hold a 33.70% share in the indication category by 2024.
- Mouthpiece PEP devices are projected to dominate with a 96.80% market share in 2024.
- Italy’s OPEP device market is set to grow at a CAGR of 5.20% from 2024 to 2034.
- Germany and China are leading with CAGRs of 5.60% and 6.00%, respectively, through 2034.
- The United States and Japan are also expected to see significant growth, with CAGRs of 5.40% and 5.60%, respectively.
Get Old Source Offers the Latest Report Editions
Competitive Landscape:
The OPEP device market is highly competitive, with several key players engaged in strategic partnerships and new product launches to capture market share. Notable developments include:
- Smith’s Medical launched the Acapella Choice Blue vibratory PEP therapy system in April 2021.
- AirPhysio received FDA approval in January 2021 for its Positive Expiratory Pressure (PEP) Device.
Essential Oscillating Positive Expiratory Pressure (OPEP) Device Manufacturers:
- Smith’s Medical, Inc.
- Allergan plc
- Monaghan Medical Corporation & Trudell Medical International
- PARI GmbH
- WyMedical Pty Ltd
- R. Cegla GmbH & Co. KG
- D-R BURTON HEALTHCARE
- AirPhysio
- Medica Holdings, LLC.
Key Segments:
- By Product Type: Face Mask PEP Devices, Mouthpiece PEP Devices, Bottle PEP Devices
- By Indication: COPD, Asthma, Atelectasis, Bronchitis, Bronchiectasis, Cystic Fibrosis, Others
- By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
- By Region: North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
